Wednesday, 05 Nov 2025

MedPulse360

Sign In

Emerging Disease-Modifying Therapies in Dravet Syndrome

14 September, 2025

Enrollment Complete for Phase 2b/3 COMBAT-ALS Study of PDE4 Inhibitor Ibudilast

14 September, 2025

Amylyx Discontinues AMX0035 Program in Supranuclear Palsy Following Disappointing Phase 2b Data

14 September, 2025

Reaction and Significance of Fremanezumab’s Expanded Indication in Pediatric Migraine: Patricia Pozo-Rosich, MD, PhD

14 September, 2025

NeuroVoices: Patricia Pozo-Rosich, MD, PhD, on Fremanezumab's Expanded Indication in Pediatrics

14 September, 2025

Building Better Pathways for Clinician Educators in Academic Neurology: Tamara Kaplan, MD

14 September, 2025

Inside Novartis’ SMAshing My Limits Campaign: Patient Voices Driving Support and Resources for SMA

14 September, 2025

Preclinical Study Reveals Potential of Multireceptor Antagonist to Block CGRP and PACAP

14 September, 2025

Merz’ IncobotulinumtoxinA Begins Phase 3 MINT Trials for Migraine Prevention

14 September, 2025

A Global Calling for Universal Levodopa Access in Parkinson Disease Treatment: Michael S. Okun, MD

14 September, 2025

📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago